Pathstone Family Office’s Medtronic MDT Stock Holding History

Pathstone Family Office’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$5.57M	Buy	70,782 +35,939	+103%	+$3.01M	0.04%	251
2023 Q2	$3.14M	Buy	34,843 +819	+2%	+$70.5K	0.04%	237
2023 Q1	$2.69M	Sell	34,024 -38,960	-53%	-$3.18M	0.04%	238
2022 Q4	$4.38M	Sell	72,984 -7,673	-10%	-$622K	0.04%	301
2022 Q3	$6.58M	Buy	80,657 +56,018	+227%	+$5.03M	0.06%	185
2022 Q2	$2.22M	Buy	24,639 +4,127	+20%	+$418K	0.05%	198
2022 Q1	$2.3M	Sell	20,512 -1,573	-7%	-$166K	0.05%	162
2021 Q4	$2.29M	Buy	22,085 +1,527	+7%	+$177K	0.06%	166
2021 Q3	$2.58M	Buy	20,558 +10,060	+96%	+$1.3M	0.08%	133
2021 Q2	$1.31M	Buy	10,498 +3,301	+46%	+$414K	0.04%	218
2021 Q1	$853K	Buy	7,197 +2,391	+50%	+$280K	0.03%	240
2020 Q4	$563K	Buy	4,806 +4,562	+1,870%	+$502K	0.02%	161
2020 Q3	$26K	Buy	244 +1	+0.4%	+$100	﹤0.01%	442
2020 Q2	$22K	Sell	243 -564	-70%	-$54.1K	﹤0.01%	413
2020 Q1	$72K	Buy	+807	New	+$85.9K	0.01%	257
2019 Q4	–	Sell	-125	Closed	-$14K	–	555
2019 Q3	$14K	Buy	125 +1	+0.8%	+$104	﹤0.01%	447
2019 Q2	$12K	Sell	124 -16	-11%	-$1.46K	﹤0.01%	504
2019 Q1	$12K	Sell	140 -2,001	-93%	-$179K	﹤0.01%	491
2018 Q4	$194K	Buy	+2,141	New	+$200K	0.06%	89
2018 Q3	–	Sell	-93	Closed	-$8K	–	251
2018 Q2	$8K	Sell	93 -131	-58%	-$10.9K	0.01%	127
2018 Q1	$18K	Buy	+224	New	+$18.5K	0.01%	168
2017 Q2	–	Sell	-108	Closed	-$9K	–	542
2017 Q1	$9K	Buy	+108	New	+$8.44K	0.01%	292
2016 Q4	–	Sell	-74	Closed	-$6K	–	164
2016 Q3	$6K	Sell	74 -63	-46%	-$5.49K	0.01%	161
2016 Q2	$11K	Sell	137 -150	-52%	-$12.1K	0.01%	131
2016 Q1	$22K	Buy	+287	New	+$21.6K	0.04%	73

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Pathstone Family Office's MDT Position: Q3 2023 in Review

Pathstone Family Office increased its Medtronic (MDT) stake by 103% in Q3 2023, buying an estimated $3.01M and bringing the position to 70,782 shares worth $5.57M. The position accounts for 0.04% of the portfolio, ranked #251.

Pathstone Family Office first reported a position in MDT in Q1 2016 and has held it in 25 quarters since. The position peaked at $6.58M in Q3 2022. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

Pathstone Family Office held 70,782 shares of Medtronic worth $5.57M as of Q3 2023.
Pathstone Family Office bought 35,939 Medtronic shares in Q3 2023, an estimated $3.01M.
Medtronic made up 0.04% of Pathstone Family Office's portfolio in Q3 2023, its #251 holding.
Pathstone Family Office first reported a position in Medtronic in Q1 2016 and has held it in 25 quarters since.
Pathstone Family Office's Medtronic position peaked at $6.58M in Q3 2022.
1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.